314

Compound name
Fostamatinib
Alt Name
R788
Tavalisse
Compound Image
Fostamatinib.jpg
SMILES
CC1(C(=O)N(c2c(ccc(n2)Nc3c(cnc(n3)Nc4cc(c(c(c4)OC)OC)OC)F)O1)COP(=O)(O)O)C
MW
580.46
Brutto
C23H26FN6O9P
InChI
InChI=1S/C23H26FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29)
InChI Key
GKDRMWXFWHEQQT-UHFFFAOYSA-N
Approval Jurisdiction
2018 FDA
Approved for clinical use
Chronic Immune Thrombocytopenia
CAS
901119-35-5
PubChem CID
11671467
Approved Drug List
1
Commercial Vendor
Seleck